Revivicor revivicor.com


Public list: Pharma Startups (4732) Animal Health Startups (186)

Revivicor's vision is the commercialization of therapies that can treat and cure serious human disease through regenerative medicine; namely, the replacement of cells, tissues, and organs. Revivicor's focus is the commercialization of treatments for diabetes and whole organ transplantation, developed from the advances made in the fields of xenografts and tolerance technologies, which are core competencies of Revivicor. In addition to the regenerative medicine portfolio, Revivicor also has a rapi...Show all

Revivicor's vision is the commercialization of therapies that can treat and cure serious human disease through regenerative medicine; namely, the replacement of cells, tissues, and organs. Revivicor's focus is the commercialization of treatments for ...Show all

Company (Acquired)

Phone: 540-961-5559

Fax:

1700 Kraft Drive
Suite 2400
Blacksburg, 24060
Virginia, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Revivicor $0M Apr 11, 2003
See all 39 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Revivicor Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

BioMimetic Therapeutics

Franklin, Tennessee, United States
AcquiredBioMimetic Pharmaceuticals (BMTI) is a biopharmaceutical company focused on the development, commercialization and ultimate marketing of protein therapeutics for tissue and organ regeneration. The Company's lead technologies are for the healing and restoration of bone and other tissues. Its lead products are based on recombinant human platelet-derived growth factor BB (rhPDGF-BB). In March 2013, BioMimetic Therapeutics was acquired by Wright Medical Group. The valuation of BioMimetic Therapeuti...Show allLogin to see details

Nurel Therapeutics

Pittsburgh, Pennsylvania, United States
AcquiredNurel is a specialty biotechnology company that is developing unique products to treat and manage pain and peripheral nerve damage. The Company's products use a proprietary drug-delivery technology derived from an engineered herpes simplex virus that provides gene-based medicine in a safe and effective manner. These products are designed to deliver therapeutic proteins for months following a single local injection into the peripheral nervous system.Login to see details
See all 39 competitors